trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
about
EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replicationEBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance.Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cellsExpression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic miceEBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomesEBNA-1, a bifunctional transcriptional activatorPotential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr VirusContributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survivalEpstein-Barr virus latent genesProtein interaction domains of the ubiquitin-specific protease, USP7/HAUSPCRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent InfectionsProtein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.Epstein-Barr virus latency switch in human B-cells: a physico-chemical model.BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.EBNA1 regulates cellular gene expression by binding cellular promotersUse of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone.Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).Distinctive charge configurations in proteins of the Epstein-Barr virus and possible functions.Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeatsTranscription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexesCTCF prevents the epigenetic drift of EBV latency promoter QpEpigenetic regulation of EBV persistence and oncogenesis.Chromatin organization of gammaherpesvirus latent genomes.Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice.Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenanceFunctional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus.DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirusGenetic selection for genes encoding sequence-specific DNA-binding proteinsEBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.Episomal vectors for gene expression in mammalian cells.A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain.Separation of the transcriptional activation and replication functions of the bovine papillomavirus-1 E2 protein.Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growthEBV latency types adopt alternative chromatin conformations.Viral latency and its regulation: lessons from the gamma-herpesviruses.Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection.The spacing between adjacent binding sites in the family of repeats affects the functions of Epstein-Barr nuclear antigen 1 in transcription activation and stable plasmid maintenanceBrd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.
P2860
Q21131571-887FA46D-DCB1-4F89-99C0-79A014B1F121Q24517055-480FA5D2-87D3-44D9-849D-BCCB011C182CQ24540313-9D817C0C-D7AB-4F26-ADE3-560B48F6E837Q24548319-CC2EDFF5-0D80-465F-AE33-A7CD1A8F8803Q24562912-F99618B3-66F0-495A-A3C3-A572B29FB9A9Q24675498-F82985AA-A84B-4950-A030-9D3B11D41816Q24682422-C9B80F4A-4317-4873-B388-12492D19D974Q26852071-69B89181-88C2-41C2-AACD-F87F473A18E5Q27003831-FD58A526-1779-4E27-AC0E-402DA78F66DFQ28082701-31B67E36-48C0-4076-BD08-9D8D5535B2CEQ28204725-C94D6A3D-80E4-4948-B0D4-0E6C27EE725EQ28552274-8969F5BC-459D-419B-B6E1-E0636CB370ACQ30941966-B2385116-C100-4483-9CC9-B7A38FEBDAF8Q33296308-EA8CFDC7-07D2-4E48-8F6E-D311B605E497Q33552058-83F7C2A1-5119-4249-BB43-947CE7D53407Q33563969-E599121E-5561-449C-8AFD-515A713D958AQ33578778-D57D4A47-5A33-45F5-9E63-3BB63147C38EQ33639938-29FF2E87-B5CE-4D5D-883D-F94A2372D020Q33646566-7792E569-858F-41F2-A91A-76D5FA98857BQ33649035-46377E58-766A-4A26-B49F-6FBE5005DCA8Q33656437-F52B3385-751E-421E-83A7-2CE88B45B0FEQ33668727-F4425389-A6FD-4FD2-AF3F-2793EBE7F4ACQ33723664-BF8EA9FD-9949-475A-BA0B-F7F6F2A41B07Q33729584-9B0E50DB-0057-4272-9791-DF5B53337F15Q33756914-442E8126-5DB1-4733-A031-2C7A185BF5D5Q33786506-6E586593-4AE1-4C60-BEF7-809F44738C85Q33787020-8E617C5F-954F-4DDE-902E-8F3B6DBB44CDQ33853499-D5FC03A1-CFFB-4D2B-9D6B-9E7DAB719C45Q33857522-8BD4FD5A-691F-429F-B225-15A0665D8FD1Q33860748-4CFE6FB4-2B4D-450F-B876-B3FB0F44CC25Q33916410-78E211CD-105D-4C5C-8310-849B20F82AA6Q33937547-6BBEF857-DD2B-4339-A5CF-F9864D5BE27AQ33938516-369AC4FC-62B2-4C40-9EE3-0202E25B02D8Q33953070-DF7F131D-6F3C-4A88-9D79-A7AF45AAE2C5Q33987454-DC5CD10B-51CB-4499-901F-B42B0FA140D2Q34039189-5435E4FE-24F7-4E0D-A92A-244F4EF7824FQ34064290-44024639-DFC1-4EFA-83C0-A27936FC19D5Q34067438-44138ACE-EF6C-433D-AB67-950263AED822Q34092739-08170792-70E9-4377-BC8C-3734808CAA72Q34107917-C8FB2A5B-A18E-4FE7-8890-05E760B1AD7E
P2860
trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
trans activation of an Epstein ...... -Barr viral nuclear antigen 1.
@en
type
label
trans activation of an Epstein ...... -Barr viral nuclear antigen 1.
@en
prefLabel
trans activation of an Epstein ...... -Barr viral nuclear antigen 1.
@en
P2860
P356
P1476
trans activation of an Epstein ...... -Barr viral nuclear antigen 1.
@en
P2093
P2860
P304
P356
10.1128/MCB.6.11.3838
P407
P577
1986-11-01T00:00:00Z